BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+4.33%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$4.41T
AUM Growth
+$133B
(+3.1%)
Cap. Flow
+$29.9B
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
27.26%
Holding
5,387
New
149
Increased
2,435
Reduced
2,097
Closed
138
Top Buys
| 1 |
Microsoft
MSFT
|
+$3.56B |
| 2 |
Exxon Mobil
XOM
|
+$3.53B |
| 3 |
GE Vernova
GEV
|
+$3.1B |
| 4 |
CRH
CRH
|
+$2.42B |
| 5 |
NVIDIA
NVDA
|
+$2.09B |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Broadcom
AVGO
|
+$1.14B |
| 5 |
Super Micro Computer
SMCI
|
+$1.12B |
Sector Composition
| 1 | Technology | 30.35% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 11.7% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
NACCO Industries
NC
$297M
| $9.42M | ﹤0.01% |
340,484
+39,014
| +13% | +$1.08M |
|
3302
Cerence
CRNC
$450M
| $9.35M | ﹤0.01% |
3,303,652
-3,673,256
| -53% | -$10.4M |
|
3303
Trevi Therapeutics
TRVI
$1B
| $9.34M | ﹤0.01% |
3,135,115
+759,406
| +32% | +$2.26M |
|
3304
Townsquare Media
TSQ
$115M
| $9.3M | ﹤0.01% |
848,578
+192,423
| +29% | +$2.11M |
|
3305
Generation Bio
GBIO
$39.9M
| $9.29M | ﹤0.01% |
329,425
+24,540
| +8% | +$692K |
|
3306
eGain
EGAN
$220M
| $9.28M | ﹤0.01% |
1,471,293
-68,554
| -4% | -$433K |
|
3307
Reservoir Media
RSVR
$517M
| $9.26M | ﹤0.01% |
1,171,971
+3,630
| +0.3% | +$28.7K |
|
3308
Virginia National Bankshares
VABK
$221M
| $9.24M | ﹤0.01% |
281,622
+2,627
| +0.9% | +$86.2K |
|
3309
Pyxis Oncology
PYXS
$113M
| $9.22M | ﹤0.01% |
2,785,895
+2,464,230
| +766% | +$8.16M |
|
3310
Achieve Life Sciences
ACHV
$157M
| $9.2M | ﹤0.01% |
1,956,510
+1,904,079
| +3,632% | +$8.95M |
|
|
NOAH
3311
Noah Holdings
NOAH
$781M
| $9.17M | ﹤0.01% |
950,519
-54,571
| -5% | -$527K |
|
3312
GrowGeneration
GRWG
$103M
| $9.12M | ﹤0.01% |
4,243,618
-104,950
| -2% | -$226K |
|
3313
EPR Properties 9.00% Series E Cumulative Convertible Preferred Shares
EPR.PRE
$111M
| $9.09M | ﹤0.01% |
326,093
-8,809
| -3% | -$246K |
|
3314
Nathan's Famous
NATH
$441M
| $9.06M | ﹤0.01% |
133,626
-7,226
| -5% | -$490K |
|
3315
Kodiak Sciences
KOD
$489M
| $9.04M | ﹤0.01% |
3,846,827
-11,794
| -0.3% | -$27.7K |
|
3316
ProKidney
PROK
$335M
| $8.99M | ﹤0.01% |
3,656,276
+924,617
| +34% | +$2.27M |
|
3317
Skye Bioscience
SKYE
$132M
| $8.96M | ﹤0.01% |
+1,118,767
| New | +$8.96M |
|
3318
Fresenius Medical Care
FMS
$14.7B
| $8.96M | ﹤0.01% |
469,403
+23,774
| +5% | +$454K |
|
3319
Nautilus Biotechnolgy
NAUT
$91M
| $8.96M | ﹤0.01% |
3,827,577
+95,773
| +3% | +$224K |
|
3320
Foghorn Therapeutics
FHTX
$293M
| $8.89M | ﹤0.01% |
1,546,069
+230,698
| +18% | +$1.33M |
|
3321
Monte Rosa Therapeutics
GLUE
$297M
| $8.83M | ﹤0.01% |
2,360,093
+53,084
| +2% | +$199K |
|
3322
Investar Holding Corp
ISTR
$223M
| $8.81M | ﹤0.01% |
572,004
+422,272
| +282% | +$6.5M |
|
3323
Rumble
RUM
$2.48B
| $8.81M | ﹤0.01% |
1,586,631
+83,868
| +6% | +$465K |
|
3324
Information Services Group
III
$253M
| $8.74M | ﹤0.01% |
2,974,478
+207,320
| +7% | +$610K |
|
3325
Southern California Bancorp
BCAL
$559M
| $8.74M | ﹤0.01% |
649,205
+485,755
| +297% | +$6.54M |
|